WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices
Recommendations to NRAs: pre-market, market and post-market oversight, pathways and implementation – WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices

WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices 9.1-stakeholders: Government and NRA: involve stakeholders throughout the regulatory process and assess the public health, economic and social impact of proposed controls

What does 9.1-stakeholders require?

To make sure requirements achieve their objectives without duplication or unnecessary barriers, policy-makers should assess the benefits, costs and side effects of proposed regulation and engage manufacturers, representatives, importers, distributors, health care providers, patients and users at every stage, considering alternatives such as economic instruments, self-regulation and voluntary standards where they would work better than law.

Maintained by Gerard Blokdyk

Other controls in Recommendations to NRAs: pre-market, market and post-market oversight, pathways and implementation – WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices

Query this from an agent

The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.

MCP endpointAll WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices controls